Drug Side Effects
Search
FLUORESCENT IN SITU HYBRIDISATION POSITIVE
FLUORESCENT IN SITU HYBRIDISATION POSITIVE
was reported 10 times
These drug classes are most commonly taken by patients reporting FLUORESCENT IN SITU HYBRIDISATION POSITIVE:
#
Drug
Count
0
Microtubule Inhibitor [EPC]
3
1
Platinum-based Drug [EPC]
3
2
Corticosteroid [EPC]
2
3
Nucleoside Metabolic Inhibitor [EPC]
2
4
Alkylating Drug [EPC]
1
5
Fluoroquinolone Antibacterial [EPC]
1
6
Integrin Receptor Antagonist [EPC]
1
7
Interleukin-12 Antagonist [EPC]
1
8
Interleukin-23 Antagonist [EPC]
1
9
Proton Pump Inhibitor [EPC]
1
10
Provitamin D2 Compound [EPC]
1
11
Thalidomide Analog [EPC]
1
12
Topoisomerase Inhibitor [EPC]
1
13
Tumor Necrosis Factor Blocker [EPC]
1